Gated single-photon emission computed tomography detects subendocardial ischemia in hypertrophic cardiomyopathy

Circulation Journal

Volumn 71, Issue 2, 2007, Pages 256-260

  Kawasaki, Tatsuya ^a   Akakabe, Yoshiki ^a   Yamano, Michiyo ^a   Miki, Shigeyuki ^a   Kamitani, Tadaaki ^a   Kuribayashi, Toshiro ^b   Sugihara, Hiroki ^a  

^a MATSUSHITA MEMORIAL HOSPITAL   (Japan)

^b Kuribayashi Clinic of Cardiology   (Japan)

Author keywords

Gated single photon emission computed tomography; Hypertrophic cardiomyopathy; Subendocardial ischemia

Indexed keywords

TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE; FEMALE; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; ROC CURVE; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; SENSITIVITY AND SPECIFICITY; SOFTWARE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33846594891     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.256     Document Type: Article

References (27)

1. Cannon RO, Dilsizian V, O'Gara PT, Udelson JE, Schenke WH, Quyyumi A, et al. Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation 1991; 83: 1660-1667.
2. Nakamura T, Sakamoto K, Yamano T, Kikkawa M, Zen K, Hikosaka T, et al. Increased plasma brain natriuretic peptide level as a guide for silent myocardial ischemia in patients with non-obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2002; 39: 1657-1663.
3. Yoshida N, Ikeda H, Wada T, Matsumoto A, Maki S, Muro A, et al. Exercise-induced abnormal blood pressure responses are related to subendocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol 1998; 32: 1938-1942.
4. Maron BJ, Tholakanahalli VN, Zenovich AG, Casey SA, Duprez D, Aeppli DM, et al. Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy. Circulation 2004; 109: 984-989.
5. Romeo F, Pelliccia F, Cristofani R, Martuscelli E, Reale A. Hypertrophic cardiomyopathy: Is a left ventricular outflow tract gradient a major prognostic determinant? Eur Heart J 1990; 11: 233-240.
6. Frenneaux MP, Counihan PJ, Caforio AL, Chikamori T, McKenna WJ. Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy. Circulation 1990; 82: 1995-2002.
7. Counihan PJ, Frenneaux MP, Webb DJ, McKenna WJ. Abnormal vascular responses to supine exercise in hypertrophic cardiomyopathy. Circulation 1991; 84: 686-996.
8. Smanio PE, Watson DD, Segalla DL, Vinson EL, Smith WH, Beller GA. Value of gating of technetium-99m sestamibi single-photon emission computed tomographic imaging. J Am Coll Cardiol 1997; 30: 1687-1692.
9. Cullon SJ, Case JA, Bateman TM. Electrocardiographically gated myocardial perfusion SPECT: Technical principles and quality control considerations. J Nucl Cardiol 1998; 5: 418-425.
10. Maron BJ, Olivotto I, Bellone P, Conte MR, Cecchi F, Flygenring BP, et al. Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002; 39: 301-307.
11. Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995; 26: 1699-1708.
12. Nishimura Y, Katafuchi T, Hirase Y, Sagoh M, Oka H, Mori H, et al. Measurement of left ventricular chamber and myocardial volume in hypertrophic cardiomyopathy patients by ECG-gated myocardial perfusion SPECT: Application of a newly developed edge-detection algorithm. Jpn J Radiol Technol 2002; 58: 1586-1591.
13. Kawasaki T, Azuma A, Kuribayashi T, Taniguchi T, Miyai N, Kamitani T, et al. Resting ST-segment depression predicts exercise-induced subendocardial ischemia in patients with hypertrophic cardiomyopathy. Int J Cardiol 2006; 107: 267-274.
14. 99mTc-tetrofosmin SPECT imaging: A study of patients with large acute myocardial infarction and receiving revascularization therapy. Circ J 2005; 69: 311-319.
15. Fukuda H, Moroi M. Prediction of cardiac events in patients with transient left ventricle dilation on stress myocardial perfusion SPECT images. Circ J 2005; 69: 1223-1229.
16. Sugihara H, Shiga K, Umamoto I, Harada Y, Katahira T, Nakagawa T, et al. Assessment of transient dilation of the left ventricular cavity in patients with hypertrophic cardiomyopathy by exercise thallium-201 scintigraphy. Jpn J Nucl Med 1990; 27: 1281-1289.
17. Sugihara H, Taniguchi Y, Ito K, Terada K, Matsumoto K, Kinoshita N, et al. Effects of diltiazem on myocardial perfusion abnormalities during exercise in patients with hypertrophic cardiomyopathy. Ann Nucl Med 1998; 12: 349-354.
18. Mazzanti M, Germano G, Kiat H, Kavanagh PB, Alexanderson E, Friedman JD, et al. Identification of severe and extensive coronary artery disease by automatic measurement of transient ischemic dilation of the left ventricle in dual-isotope myocardial perfusion SPECT. J Am Coll Cardiol 1996; 27: 1612-1620.
19. Germano G, Kiot H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995; 36: 2138-2147.
20. Bavelaar-Croon CDL, Pauwels EKJ, van der Wall EE. Gated single-photon emission computed tomographic myocardial imaging: A new tool in clinical cardiology. Am Heart J 2001; 141: 383-390.
21. Go V, Bhatt MR, Hendel RC. The diagnostic and prognostic value of ECG-gated SPECT myocardial perfusion imaging. J Nucl Med 2004; 45: 912-921.
22. Bonow RO. Gated myocardial perfusion imaging for measuring left ventricular function. J Am Coll Cardiol 1997; 30: 1649-1650.
23. Manrique A, Hitzel A, Brasse D, Vera P. Effect of perfusion pattern and imaging sequence on gated perfusion SPECT evaluation of myocardial stunning. J Nucl Med 2005; 46: 176-183.
24. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: Incremental prognostic value and use in risk stratification. Circulation 1996; 93: 905-914.
25. Feng B, Sitek A, Gullberg GT. Calculation of the left ventricular ejection fraction without edge detection: Application to small hearts. J Nucl Med 2002; 43: 786-794.
26. Ford PV, Chatziioannou SN, Moore WH, Dhekne RD. Overestimation of the LVEF by quantitative gated SPECT in simulated left ventricles. J Nucl Med 2001; 42: 454-459.
27. O'Gara PT, Bonow RO, Maron BJ, Damske BA, Van Lingen A, Bacharach SL, et al. Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: Assessment with thallium-201 emission computed tomography. Circulation 1987; 76: 1214-1223.